| Chloroquine and hydroxychloroquine for the treatment of COVID-19: a systematic review and meta-analysis A Elavarasi, M Prasad, T Seth, RK Sahoo, K Madan, N Nischal, M Soneja, ... Journal of general internal medicine 35, 3308-3314, 2020 | 152 | 2020 |
| Sleep quality and quantity in intensive care unit patients: a cross-sectional study RD Naik, K Gupta, M Soneja, A Elavarasi, V Sreenivas, S Sinha Indian journal of critical care medicine: peer-reviewed, official …, 2018 | 64 | 2018 |
| Consensus and evidence-based Indian initiative on obstructive sleep apnea guidelines 2014 SK Sharma, VM Katoch, A Mohan, T Kadhiravan, A Elavarasi, R Ragesh, ... Lung India 32 (4), 422-434, 2015 | 46 | 2015 |
| Consensus & evidence-based INOSA Guidelines 2014 SK Sharma, VM Katoch, A Mohan, T Kadhiravan, A Elavarasi, R Ragesh, ... Indian Journal of Medical Research 140 (3), 451-468, 2014 | 26 | 2014 |
| Efficacy and safety of convalescent plasma for COVID-19: a systematic review and meta-analysis M Prasad, T Seth, A Elavarasi Indian Journal of Hematology and Blood Transfusion 37 (3), 347-365, 2021 | 23 | 2021 |
| Practice trends in treating central nervous system tuberculosis and outcomes at a tertiary care hospital: A cohort study of 244 cases V Goyal, A Elavarasi, G Shukla, M Behari Annals of Indian Academy of Neurology 22 (1), 37-46, 2019 | 17 | 2019 |
| Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial … N Pathak, A Sharma, A Elavarasi, J Sankar, SVS Deo, DN Sharma, ... The Breast 64, 7-18, 2022 | 16 | 2022 |
| Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous?-A retrospective cohort study P Sirohiya, A Elavarasi, HKR Sagiraju, M Baruah, N Gupta, RK Garg, ... Lung India 39 (3), 247-253, 2022 | 16 | 2022 |
| Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort study A Elavarasi, HKR Sagiraju, RK Garg, B Ratre, P Sirohiya, N Gupta, ... Lung India 39 (1), 16-26, 2022 | 16 | 2022 |
| Handbook of trigeminal neuralgia GP Rath Springer, 2019 | 16 | 2019 |
| Spinal cord involvement in primary CNS lymphoma A Elavarasi, D Dash, AR Warrier, R Bhatia, L Kumar, D Jain, M Tripathi Journal of Clinical Neuroscience 47, 145-148, 2018 | 13 | 2018 |
| The effectiveness of SARS-CoV-2 vaccination in preventing severe illness and death–real-world data from a cohort of patients hospitalized with COVID-19 HKR Sagiraju, A Elavarasi, N Gupta, RK Garg, SS Paul, S Vig, P Sirohiya, ... Indian Journal of Community Medicine 47 (4), 510-516, 2022 | 12 | 2022 |
| Primary CNS vasculitis (PCNSV): a cohort study A Agarwal, J Sharma, MVP Srivastava, MC Sharma, R Bhatia, D Dash, ... Scientific Reports 12 (1), 13494, 2022 | 11 | 2022 |
| Acute ischemic stroke due to multiple bee Stings_A delayed complication A Elavarasi, TM Haq, T Thahira, C Bineesh, LB Kancharla Annals of Indian Academy of Neurology 23 (1), 135-136, 2020 | 11 | 2020 |
| Clinical features and outcome of stroke with COVID-19. COVID-19 stroke study group (CSSG), India R Bhatia, MVP Srivastava, PN Sylaja, S Komakula, A Upadhyay, ... Annals of Indian Academy of Neurology 24 (5), 668-685, 2021 | 9 | 2021 |
| Is triamcinolone an easy and efficient way to treat meralgia paresthetica? A cohort study A Elavarasi, V Goyal, MB Singh, MVP Srivastava Annals of Indian Academy of Neurology 22 (3), 308-310, 2019 | 9 | 2019 |
| Indian Initiative on Obstructive Sleep Apnoea Guidelines Working Group; Indian Initiative on Obstructive Sleep. Consensus & evidence-based INOSA Guidelines 2014 SK Sharma, VM Katoch, A Mohan, T Kadhiravan, A Elavarasi, R Ragesh Indian J Med Res 140, 451-68, 2014 | 8 | 2014 |
| Clinical and radiological spectrum of anti-myelin oligodendrocyte glycoprotein (MOG) antibody encephalitis: single-center observational study M Salunkhe, P Gupta, RK Singh, K Tayade, V Goel, A Agarwal, A Das, ... Neurological Sciences 44 (7), 2475-2489, 2023 | 5 | 2023 |
| Botulinum toxin to treat phantom limb pain A Elavarasi, V Goyal Toxicon 195, 17-19, 2021 | 5 | 2021 |
| Hydroxychloroquine and myasthenia gravis-can one take this risk? A Elavarasi, V Goyal Annals of Indian Academy of Neurology 23 (3), 360-361, 2020 | 5 | 2020 |
